Management of Atopic Dermatitis: Bringing Therapy Into Focus

Saakshi Khattri, MD


June 29, 2022

Saakshi Khattri, MD, recounts the evolution of treatments for atopic dermatitis (AD), from the widespread use of general immune suppressants such as methotrexate and cyclosporine, to more recent, targeted agents such as dupilumab and tralokinumab.

This steady stream of approved agents, Dr Khattri contends, has allowed for greater refinement in therapeutic approach and an enhanced focus in the treatment of this debilitating disease.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.